Related Experiment Video
Updated: Aug 9, 2026
Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice
Published on: October 3, 2011
Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice
Ming S Tsai1, Yung T Chiu, Sue H Wang
1Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
Abstract:
Spinal muscular atrophy (SMA) is the most common genetic motoneuron degenerative disorder, but the mechanism(s) of motoneuron degeneration is unclear. We previously generated SMA model mice, which genotypically and phenotypically mimicked human SMA patients, by a combination of knockout and transgenic techniques. Here, we used these SMA model mice to decipher the apoptotic mechanism(s) involved in SMA motoneuron degeneration. We found a significant increase in proapoptotic Bax expression in the spinal cords of SMA mice in comparison with their wild-type littermates. After crossing SMA mice with Bax knockout mice, we produced in vivo evidence indicating that Bax protein plays an important role in the degeneration of SMA spinal motoneurons. Progeny Bax-deficient SMA mice showed milder disease severity, longer life spans, and significant increases in spinal motoneuron densities compared to SMA littermates with wild-type Bax genes. Our results strongly suggest that suppression of Bax-involved apoptosis has the potential for amelioration of SMA.
Insights
Spinal muscular atrophy (SMA) involves increased Bax protein, a key factor in cell death. Suppressing Bax-dependent apoptosis in SMA mice improved motor neuron survival and reduced disease severity, offering a potential therapeutic strategy.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Spinal muscular atrophy (SMA) is a common genetic disorder affecting motor neurons.
- The precise mechanisms driving motor neuron degeneration in SMA remain unclear.
Purpose of the Study:
- To investigate the role of apoptosis in SMA-related motor neuron degeneration.
- To determine if targeting the Bax protein could ameliorate SMA pathology.
Main Methods:
- Utilized genetically engineered SMA model mice that mimic human SMA.
- Compared Bax protein expression in SMA mice versus wild-type littermates.
- Generated and analyzed Bax-deficient SMA mice to assess in vivo effects.
Main Results:
- SMA mice exhibited significantly elevated proapoptotic Bax expression in spinal cords.
- Bax-deficient SMA mice displayed reduced disease severity and extended lifespan.
- These mice also showed increased spinal motor neuron density compared to SMA mice with functional Bax.
Conclusions:
- Bax protein plays a critical role in SMA motor neuron degeneration.
- Inhibition of Bax-mediated apoptosis presents a promising therapeutic avenue for SMA treatment.
